NASDAQ : SIGA
SIGA Technologies, Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 3.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 218.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Details
| Name | SIGA Technologies, Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 49 |
| Founded | 1995 |
| Ipo Date | 1997-09-09 |
| Ceo | Diem Nguyen |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US8269171067 |
| Cusip | 826917106 |
| Cik | 0001010086 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Diem Nguyen M.B.A., Ph.D. | Chief Executive Officer and Director |
| Daniel J. Luckshire CPA, M.B.A. | Executive Vice President, Chief Financial Officer and Secretary |
| Dr. Dennis E. Hruby Ph.D. | Executive Vice President and Chief Scientific Officer |
| Lawrence R. Miller Esq., J.D. | General Counsel and Corporate Secretary |
| Herb Vloedman | Senior Vice President and Chief Information Officer |
| Suzanne Harnett | Senior Vice President of Corporate Affairs and Investor Relations |
Contact
| Address | 31 East 62nd Street, New York, New York 10065, United States |
| Phone | 212 672 9100 |
| Website | https://www.siga.com |